From Lipedema to Lipalgia: Understanding the New Medical Perspective
Learn why the term lipalgia is increasingly being used instead of lipedema, and how the focus is shifting from edema to pain, adipose tissue, diagnosis, and evidence-based treatment.
From Lipedema to Lipalgia: Why This Change Matters
For decades, the condition has been known as lipedema.
The term has become familiar to patients, physicians, physiotherapists, and other healthcare professionals. However, the name itself may be misleading because it places edema at the center of the condition.
Recent scientific and clinical discussions are increasingly challenging that assumption.
I will now use the term “Lipalgia Syndrome”, formerly lipedema, to better reflect the nature of the condition. The clinic emphasizes that this is not simply a change in terminology, but a change in medical understanding.
Why the term “lipedema” may be misleading
The word lipedema combines two ideas:
lipo — adipose tissueedema — excess fluid in the tissues
The name therefore naturally suggests that fluid accumulation and lymphatic dysfunction are central features of the disease.
However, current evidence increasingly questions this concept.
Several studies using high-resolution ultrasound, MR lymphography, histology, molecular biology, and indocyanine green lymphography have also reported no consistent evidence of significant fluid accumulation or primary lymphatic dysfunction in patients with pure lipedema.
From swelling to pain
If edema is not the defining feature, what should be placed at the center of the condition?
Pain.
This is the key concept behind the term lipalgia.
The word comes from:
lipos — fatalgos — pain
The new terminology therefore focuses on one of the most important clinical features: painful adipose tissue.
This represents a major shift in perspective.
Instead of viewing the disease primarily as a problem of swelling and fluid accumulation, lipalgia emphasizes the combination of:
● disproportionate adipose tissue,
● clinically significant pain,
● tissue sensitivity,
● functional impairment,
● and the need for individualized medical assessment.
Lipalgia is not simply a cosmetic condition
One of the most important aspects of this change is the recognition that the condition cannot be reduced to body shape or appearance.
Patients may experience significant pain, tenderness, heaviness, reduced mobility, difficulty with physical activity, and substantial impact on quality of life.
This is why lipedema should be approached as a medical condition, not simply as an aesthetic concern.
At the same time, not every disproportionate fat distribution should be diagnosed as lipedema.
Two key diagnostic features must be highlighted :
a disproportionate increase in adipose tissue of the extremities;
relevant pain in that tissue.
When disproportionate adipose tissue is present without clinically significant pain, lipohypertrophy may be a more appropriate term.
Why terminology changes treatment
Medical terminology shapes medical treatment.
If a condition is understood primarily as an edema disorder, treatment may focus on removing or redistributing fluid.
But if there is no edema to decongest, the therapeutic strategy must change.
This is why the Földi Clinic no longer uses manual lymphatic drainage as a standard treatment for pure lipalgia syndrome. When a true lymphedema or another cause of edema coexists, appropriate decongestive therapy is still indicated.
The principle is simple:
Treat what is actually present, not what the historical name suggests.
Compression still has a role
Compression remains an important part of conservative management.
However, its purpose is not necessarily the same as in lymphedema.
In lipalgia, compression may be used to:
● reduce pain,
● support soft tissues,
● improve comfort during activity,
● and help patients remain physically active.
The focus shifts from decongestion to pain control and function.
Lipalgia and lymphedema are different conditions
Another important consequence of this new understanding is distinguishing lipalgia from lymphedema.
They should be considered separate conditions that may coexist in the same patient.
The Földi Clinic therefore recommends moving away from the term “lipolymphedema”, which may imply that one condition inevitably progresses into the other.
A patient may have:
● lipalgia,
● lymphedema,
● or both.
But they should not automatically be considered the same disease process.
Why this matters for patients
Changing terminology can initially create uncertainty.
But a more accurate name may ultimately help patients receive:
● a more precise diagnosis,
● more appropriate treatment,
● better explanations of their symptoms,
● fewer unnecessary therapies,
● and more realistic expectations.
The transition from lipedema to lipalgia therefore represents more than a change in vocabulary.
It reflects a broader change in medical thinking:
from swelling to pain,from fluid to adipose tissue,from appearance to function,and from historical assumptions to evidence-based care.
A more precise way forward
The term lipedema will remain widely used for some time, especially in scientific literature, medical records, and insurance systems.
But the concept of lipalgia syndrome reflects an important evolution in how we understand the condition.
The goal is not to erase the disease's history.
The goal is to describe it more accurately, diagnose it more carefully, and treat patients according to their actual symptoms and clinical findings.
That is why the transition from lipedema to lipalgia matters.
Comments